Cara Mia Dermatology - Poplar (Colorado)

866-269-0309

Research Studies at Denver, Colorado

Cara Mia Dermatology 
3540 S Poplar St, Ste 300
Denver, CO 80237

 

Atopic Dermatitis

Males and Females, Ages 18+ years old. Qualifying patients will have a diagnosis of Atopic Dermatitis by a dermatologist or qualified dermatology provider and has been prescribed an eligible medication.

AD is a chronic skin condition that can cause dry, itchy patches, discoloration of the skin, and inflammation. This trial is evaluating an approved drug for adults whose AD has not improved with previous treatment.

 

Study Details

The objective of the CorEvitas Atopic Dermatitis (AD) Registry is to create a national cohort of patients with atopic dermatitis. Data collected will be used to extensively evaluate the effectiveness and safety of medications used to treat atopic dermatitis. This will be done through the standardized collection of patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), and the prevalence and incidence of comorbidities and adverse events, medication utilization patterns, and patient productivity measures.

Compensation: $25 per completed visit
Duration: Every 6 months
Visits: 12

 

Atopic Dermatitis (AD or Eczema)

Males and Females, Ages 18+ years old. Qualifying patients will have a diagnosis of Atopic Dermatitis by a dermatologist or qualified dermatology provider and has been prescribed an eligible medication.

AD is a chronic, relapsing inflammatory skin disease that significantly burdens the patient’s quality of life.

 

Study Details

This is a study of post approval drug safety and effectiveness with an optional biorepository. There will be no visits required outside of the patient’s standard of care.

Compensation: $25 per routine standard of care visit post enrollment in the study and $100 for the biorepository

 

 

Chronic Spontaneous Urticaria (Hives)

Males and Females, Ages 18+ years old. Qualifying patients will present with chronic spontaneous urticaria (hives).

Chronic urticaria is a condition characterized by the presence of hives, or wheals, on the skin that last for more than six weeks, often accompanied by itching and swelling. 

 

Study Details

This is a non-interventional prospective, multi-country, effectiveness and safety study to evaluate the treatment of chronic spontaneous urticaria.

Compensation: Up to $461
Duration: 2 years
 

 

Lichen Planopilaris (LPP)

Males and Females, Ages 18+ years old. Qualifying patients will present with a histologically confirmed diagnosis of lichen planopilaris (LPP).

LPP is an autoimmune inflammatory condition that causes scarring and permanent hair loss on the scalp by destroying hair follicles. It leads to symptoms such as redness and scale around hair follicles, itching, burning, tenderness, and bald patches.

 

Study Details

This is a phase 2/3 randomized, double-blind, placebo-controlled study to investigate the safety and efficacy of oral investigational drug in adults with LPP. Enrolled subjects will participate in a 24-week blinded treatment period and then have the option to continue in an open label extension lasting an additional 24-weeks.

Compensation: Up to $1,125
Duration: Up to 56 weeks
Visits: 13

 

Immediate appointments available at many of our 150+ Locations

BOOK AN APPOINTMENT 866-400-3376

Cosmetics/aesthetics 800-647-9851

Added to Cart​

Checkout​

Images are loading, please wailt a minute.

Thank you for reaching out. Our staff will contact you within 24 hours!
Cannot submit your request. Please try again later
close popup